ARMATA PHARMACEUTICALS INC

Armata Pharma CEO Sells 14,041 Shares Amid Volatile Stock, Investors Watch Insider Moves Closely

Armata CEO sells 14,041 shares to cover tax obligations amid a 66% yearly slump, yet FDA pediatric study plans signal long‑term growth prospects.

ARMATA PHARMACEUTICALS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

14/07/2026, 22:34

3 minutes to read

Armata Pharmaceuticals Grants Premium Options to CEO, Director Amid Bacteriophage Breakthroughs

Armata Pharmaceuticals 2026 option grants reveal executive confidence in its phage‑therapy pipeline—CEO awards, share price rally, and long‑term incentives highlighted.

ARMATA PHARMACEUTICALS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/03/2026, 11:38

3 minutes to read